{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:46:02Z","timestamp":1758631562310,"version":"3.37.3"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:00:00Z","timestamp":1491436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea (KR)","award":["NRF-2013R1A1A2060008"],"award-info":[{"award-number":["NRF-2013R1A1A2060008"]}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI13C0826"],"award-info":[{"award-number":["HI13C0826"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175384","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T20:06:58Z","timestamp":1491509218000},"page":"e0175384","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Universal vaccine against respiratory syncytial virus A and B subtypes"],"prefix":"10.1371","volume":"12","author":[{"given":"Jeong-Yoon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-5987","authenticated-orcid":true,"given":"Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1067\/S0022-3476(03)00508-0","article-title":"Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection","volume":"143","author":"RC Welliver","year":"2003","journal-title":"J Pediatr-Us"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.inf.0000108192.94692.d2","article-title":"Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection","volume":"23","author":"TR Johnson","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"Pt 11","key":"ref3","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1099\/0022-1317-70-11-2953","article-title":"Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins","volume":"70","author":"EE Walsh","year":"1989","journal-title":"J Gen Virol"},{"issue":"Pt 10","key":"ref4","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-66-10-2111","article-title":"Two distinct subtypes of human respiratory syncytial virus","volume":"66","author":"MA Mufson","year":"1985","journal-title":"J Gen Virol"},{"issue":"6","key":"ref5","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"WP Glezen","year":"1986","journal-title":"Am J Dis Child"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"CB Hall","year":"1991","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"ref7","first-page":"77","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"31","author":"AR Falsey","year":"2005","journal-title":"Exp Lung Res"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/JVI.68.8.5321-5325.1994","article-title":"Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10","volume":"68","author":"M Connors","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1203\/00006450-197601000-00015","article-title":"Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection","volume":"10","author":"HW Kim","year":"1976","journal-title":"Pediatr Res"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"HW Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0264-410X(89)90008-X","article-title":"Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus","volume":"7","author":"PA Piedra","year":"1989","journal-title":"Vaccine"},{"issue":"14","key":"ref12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0264-410X(93)90170-3","article-title":"Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon","volume":"11","author":"PA Piedra","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.186.3.421","article-title":"Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection","volume":"186","author":"A Srikiatkhachorn","year":"1997","journal-title":"J Exp Med"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1128\/JVI.70.11.7783-7791.1996","article-title":"Generation of atypical pulmonary inflammatory responses in BALB\/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus","volume":"70","author":"GE Hancock","year":"1996","journal-title":"J Virol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/intimm\/4.4.493","article-title":"Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G","volume":"4","author":"PJ Openshaw","year":"1992","journal-title":"Int Immunol"},{"issue":"38","key":"ref16","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2010.07.011","article-title":"Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein","volume":"28","author":"Y Murata","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.73.7.5637-5645.1999","article-title":"Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein","volume":"73","author":"H Plotnicky-Gilquin","year":"1999","journal-title":"J Virol"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"PW Tebbey","year":"1998","journal-title":"Journal of Experimental Medicine"},{"issue":"Pt 10","key":"ref19","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1099\/0022-1317-78-10-2411","article-title":"Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein","volume":"78","author":"JA Melero","year":"1997","journal-title":"J Gen Virol"},{"issue":"3","key":"ref20","first-page":"193","article-title":"Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains","volume":"25","author":"Y Choi","year":"2012","journal-title":"Viral Immunol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1086\/425516","article-title":"Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis","volume":"190","author":"JL Harcourt","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice","volume":"84","author":"W Zhang","year":"2010","journal-title":"J Virol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"MR Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"4 Suppl","key":"ref24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"J Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"51","key":"ref25","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1016\/j.vaccine.2007.09.073","article-title":"Sublingual immunization induces broad-based systemic and mucosal immune responses in mice","volume":"25","author":"N Cuburu","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/491739","article-title":"Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: Implications for the use of AB toxins as adjuvants in intranasal vaccines","volume":"192","author":"ME Armstrong","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"ref27","article-title":"Evaluation of Protective Efficacy of Respiratory Syncytial Virus Vaccine against A and B Subgroup Human Isolates in Korea","volume":"6","author":"JE Jang","year":"2011","journal-title":"Plos One"},{"issue":"2","key":"ref28","article-title":"Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant","volume":"7","author":"S Kim","year":"2012","journal-title":"Plos One"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094269","article-title":"Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)","volume":"9","author":"IS Cheon","year":"2014","journal-title":"Plos One"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1078\/1438-4221-00241","article-title":"Role of secretory antibodies in the defence against infections","volume":"293","author":"P Brandtzaeg","year":"2003","journal-title":"Int J Med Microbiol"},{"issue":"17\u201319","key":"ref31","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0264-410X(00)00525-9","article-title":"Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein","volume":"19","author":"UF Power","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0042-6822(91)90546-N","article-title":"Protection of BALB\/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein","volume":"185","author":"M Trudel","year":"1991","journal-title":"Virology"},{"issue":"36","key":"ref33","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.vaccine.2012.06.016","article-title":"Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice","volume":"30","author":"Y Murata","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-9071(199603)48:3<253::AID-JMV7>3.0.CO;2-7","article-title":"Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection","volume":"48","author":"PA Cane","year":"1996","journal-title":"J Med Virol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.4049\/jimmunol.165.11.6487","article-title":"The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2CD4(+) T cell responses","volume":"165","author":"SM Varga","year":"2000","journal-title":"Journal of Immunology"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1128\/JVI.73.8.6590-6597.1999","article-title":"Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent","volume":"73","author":"A Srikiatkhachorn","year":"1999","journal-title":"Journal of Virology"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1074-7613(01)00209-6","article-title":"Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells","volume":"15","author":"SM Varga","year":"2001","journal-title":"Immunity"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.168.6.2944","article-title":"The role of IFN in respiratory syncytial virus pathogenesis","volume":"168","author":"JE Durbin","year":"2002","journal-title":"Journal of Immunology"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.74.8.3455-3463.2000","article-title":"CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB\/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment","volume":"74","author":"H Plotnicky-Gilquin","year":"2000","journal-title":"Journal of Virology"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0162-3109(00)00233-2","article-title":"Immune-mediated disease pathogenesis in respiratory syncytial virus infection","volume":"48","author":"BS Graham","year":"2000","journal-title":"Immunopharmacology"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.179.1.81","article-title":"Distinct types of lung disease caused by functional subsets of antiviral T cells","volume":"179","author":"WH Alwan","year":"1994","journal-title":"J Exp Med"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.73.9.7099-7107.1999","article-title":"Respiratory syncytial virus G and\/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB\/c mice","volume":"73","author":"RA Tripp","year":"1999","journal-title":"J Virol"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.181.10.6692","article-title":"Cutting Edge: Eosinophils Do Not Contribute to Respiratory Syncytial Virus Vaccine-Enhanced Disease","volume":"181","author":"EM Castilow","year":"2008","journal-title":"J Immunol"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/pr.2015.143","article-title":"The role of Th17 and Treg responses in the pathogenesis of RSV infection","volume":"78","author":"TC Mangodt","year":"2015","journal-title":"Pediatric Research"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/v5030777","article-title":"Th17 Lymphocytes in Respiratory Syncytial Virus Infection","volume":"5","author":"J Bystrom","year":"2013","journal-title":"Viruses-Basel"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajpath.2011.03.003","article-title":"IL-17-Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease","volume":"179","author":"S Mukherjee","year":"2011","journal-title":"American Journal of Pathology"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"e5190","DOI":"10.1371\/journal.pone.0005190","article-title":"Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens","volume":"4","author":"JB Lee","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1086\/425516","article-title":"Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis","volume":"190","author":"JL Harcourt","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB\/c Mice","volume":"200","author":"LM Haynes","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"18","key":"ref50","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.77.18.9831-9844.2003","article-title":"Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P","volume":"77","author":"LM Haynes","year":"2003","journal-title":"Journal of Virology"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice","volume":"84","author":"WL Zhang","year":"2010","journal-title":"Journal of Virology"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e318282603a","article-title":"Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea","volume":"32","author":"HS Jafri","year":"2013","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"9","key":"ref53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.rmed.2004.01.009","article-title":"Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants?","volume":"98","author":"NG Papadopoulos","year":"2004","journal-title":"Resp Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T03:28:52Z","timestamp":1601868532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175384"}},"subtitle":[],"editor":[{"given":"Steven M.","family":"Varga","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,6]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,4,6]]}}}